Company Filing History:
Years Active: 2018
Title: Rasmus Goll: Innovator in Inflammatory Bowel Disease Research
Introduction
Rasmus Goll is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of medical research, particularly in understanding inflammatory bowel disease (IBD). His innovative work focuses on improving patient outcomes through advanced diagnostic methods.
Latest Patents
Rasmus Goll holds a patent for a method that determines whether a patient with inflammatory bowel disease, who has been treated with anti-TNFα therapy, is in immunological remission. This method involves measuring the levels of specific cytokines, including TNFα, IL-17, and IFN-γ, in a gastrointestinal mucosal sample. The invention also outlines methods for prognosis and treatment, emphasizing the importance of adjusting therapy based on the patient's immunological status.
Career Highlights
Goll is affiliated with the University of Tromsø, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential to enhance treatment strategies for patients suffering from IBD.
Collaborations
Rasmus Goll has worked alongside esteemed colleagues such as Jon Florholmen and Trine Olsen. Their collaborative efforts have contributed to advancing the understanding and treatment of inflammatory bowel disease.
Conclusion
Rasmus Goll's innovative approach to diagnosing and treating inflammatory bowel disease showcases the impact of research on patient care. His contributions are vital in the ongoing quest to improve health outcomes for individuals affected by this condition.